Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Medicare physician fee schedule final rule 2026.

Medicare Physician Fee Schedule cuts cardiologist pay because CMS says doctors should be more efficient

The new, negative 2.5% efficiency adjustment will be applied to the vast majority of Medicare payments for physician services. It was opposed by cardiology and most other medical societies. 

Medicare money bills dollars

Medicare releases 2026 physician fee schedule, finalizing cuts opposed by radiology

Medicare is finalizing a controversial “efficiency adjustment” and cuts related to practice expenses—both opposed by imaging groups earlier this year. 

Medicare Money

CMS 2026 physician fee schedule emphasizes chronic disease management, includes pay raise

The Centers for Medicare & Medicaid Services announced a 3.26% reimbursement increase for all providers, with those enrolled in alternative payment models seeing a higher rise.

At the recent American College of Cardiology (ACC) Legislative Committee meeting, leaders warned that ongoing federal policy uncertainty threatens patient access and the stability of cardiovascular care. Cathie Biga, MSM, immediate past president of the ACC, outlined growing concerns over telehealth, shrinking Medicare reimbursement, and mounting physician workforce shortages driven by visa restrictions.

ACC raises red flags over telehealth, payment reform and the cardiologist shortage

"We need telehealth the way we had it for COVID," Cathie Biga told Cardiovascular Business at TCT 2025. "We don't want to go back to having it so restricted."

rope pulling tug of war bidding war

Novo Nordisk, Pfizer enter bidding war for biotech startup—and it is getting ugly

Pfizer was all set to acquire New York City-based Metsera for $4.9 billion, but Novo Nordisk stepped in with an unexpected counteroffer of $6.5 billion. Both companies hope to add Metsera's drugs to their GLP-1 portfolios.

healthcare business deal

Rural hospital switches radiology providers to address lagging wait times

Hillsdale Hospital has entered an agreement with Kalamazoo, Michigan-based Premier Radiology, with the new arrangement starting Oct. 21. 

stock market IPO

Private equity-backed Medline files for IPO

The company, founded in 1966, has been providing supplies to cardiac surgery suites and cath labs for decades.

An Illinois appellate judge upheld a pervious trial victory that cleared and central Illinois cardiologist Amit Dande, MD, and Prairie Cardiovascular Consults LLP of alleged misdiagnosis of the severity of a patient's heart condition that led to his death prior to a schedule percutaneous coronary intervention (PCI).

Medical malpractice reforms appear to curb unnecessary imaging in ED

State caps on malpractice damages were associated with a roughly 21% decrease in low-value imaging use for headaches, according to new Neiman Policy Institute research.